Skip to main content

MoneyWorks4Me

Genpharmasec - Quaterly Results

13 Aug 2024 Evaluate
The sales declined to Rs. 53.03 millions for the June 2024 quarter as compared to Rs. 59.64 millions during the corresponding quarter last year.Net Profit for the quarter ended June 2024 zoomed to 2165.38% from Rs. 0.26 millions to Rs. 5.89  millions.Operating profit surged to 8.08 millions from the corresponding previous quarter of 1.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 53.03 59.64 -11.08 53.03 59.64 -11.08 304.06 255.16 19.16
Other Income 5.78 1.12 416.07 5.78 1.12 416.07 7.18 1.00 618.00
PBIDT 8.08 1.34 502.99 8.08 1.34 502.99 8.78 3.58 145.25
Interest 0.71 0.63 12.70 0.71 0.63 12.70 3.95 0.56 605.36
PBDT 7.37 0.71 938.03 7.37 0.71 938.03 4.83 3.02 59.93
Depreciation 0.05 0.07 -28.57 0.05 0.07 -28.57 0.17 0.20 -15.00
PBT 7.32 0.64 1043.75 7.32 0.64 1043.75 4.66 2.82 65.25
TAX 1.43 0.38 276.32 1.43 0.38 276.32 4.20 -8.43 -149.82
Deferred Tax 1.43 0.38 276.32 1.43 0.38 276.32 4.20 -8.43 -149.82
PAT 5.89 0.26 2165.38 5.89 0.26 2165.38 0.46 11.25 -95.91
Equity 553.72 276.86 100.00 553.72 276.86 100.00 553.72 276.86 100.00
PBIDTM(%) 15.24 2.25 578.15 15.24 2.25 578.15 2.89 1.40 105.82
Peers
Company Name CMP
Redington 327.50
Adani Enterprises 2735.00
Amrapali Industries 33.57
Maxgrow India 172.35
Rashi Peripheral 738.20
View more..